Stocks to Watch for February 26: IRFC, Tata Capital, Lupin, KFin Tech and more

By Admin

26 Feb, 2026

As markets gear up for Thursday’s trading session, several companies across financial services, pharmaceuticals, renewable energy, and manufacturing have announced important financial and operational developments. Here’s a detailed look at the key stocks likely to remain in focus on February 26.

🚆 Indian Railway Finance Corporation (IRFC)

Indian Railway Finance Corporation Ltd

IRFC will remain in the spotlight after the government confirmed it will not exercise the oversubscription (green shoe) option in the ongoing Offer for Sale (OFS).

• The Centre is divesting a 2% stake at a floor price of ₹104 per share.
  
  

• The OFS opened for non-retail investors on February 25 and will open for retail investors on February 26.
  
  

• Earlier, an additional 2% green shoe option was indicated, potentially taking total divestment to 4%, but this will not be exercised.
  
  

Additionally, IRFC raised a $400 million equivalent JPY-denominated External Commercial Borrowing (ECB) from SMBC and MUFG’s GIFT City branches to fund railway-linked projects strengthening its funding base.

🏦 Tata Capital Ltd

Tata Capital Ltd

The NBFC announced that its wholly owned subsidiary, Tata Capital Housing Finance Ltd, has approved a ₹650.02 crore rights issue of equity shares to its parent.

• Shares of ₹10 each will be issued.
  
  

• The rights issue will be executed in one or more tranches.
  
  

This move is aimed at strengthening capital adequacy and supporting future lending growth.

💊 Lupin

Lupin Limited

The pharmaceutical major informed exchanges that the Maharashtra GST Department has initiated an inspection and search at its office.

• The inspection relates to GST payments and input tax credit claims.
  
  

• The company stated it is fully cooperating with authorities.
  
  

• Importantly, it clarified that the proceedings have no financial or operational impact.
  
  

Investors may track developments for any regulatory updates.

📈 KFin Technologies Ltd

KFin Technologies Ltd

KFin Tech announced leadership changes at its joint venture, MFC Technologies.

• Rajesh Krishnamoorthy has been appointed as CEO.
  
  

• Supratim Bandyopadhyay has been named Non-Executive Chairman.
  
  

The restructuring is intended to strengthen governance as MF Central evolves into a professionally managed standalone entity serving India’s mutual fund ecosystem.

💰 SBI Life Insurance

SBI Life Insurance Company Limited

The insurer declared an interim dividend of ₹2.70 per equity share (27%) for FY26.

• Record date: March 6, 2026
  
  

• Payment by: On or before March 27, 2026
  
  

Dividend announcements typically draw attention from income-focused investors.

🏭 Reliance Industries Ltd

Reliance Industries Ltd

Reliance Enterprise Intelligence Ltd has become a step-down subsidiary of RIL after the allotment of 85.32 crore shares.

• 70% allotted to Reliance Intelligence Ltd
  
  

• 30% allotted to Facebook Overseas, Inc., a wholly owned arm of Meta Platforms, Inc.
  
  

This development highlights strategic expansion in the digital and intelligence ecosystem.

🧪 Zydus Lifesciences

Zydus Lifesciences Ltd

The company has received DCGI approval to manufacture and market semaglutide injections for Type 2 diabetes and obesity.

• Brands: SEMAGLYN™, MASHEMA™, ALTERMET™
  
  

• Features an indigenously developed adjustable, reusable single-pen delivery system.
  
  

This approval positions Zydus strongly in the fast-growing diabetes and obesity therapy market.

📦 Aditya InfoTech

Aditya InfoTech Ltd

In a block deal, Dixon Technologies sold a 3.8% stake for ₹661 crore.

Major buyers included:

• Motilal Oswal Mutual Fund
  
  

• Kotak Mahindra Mutual Fund
  
  

• Axis Mutual Fund
  
  

• HDFC Life Insurance
  
  

• 360 One Mutual Fund
  
  

Large institutional participation signals continued investor interest.

☀️ Emmvee Photovoltaic Power Ltd

Emmvee Photovoltaic Power Ltd

The company clarified that recent US countervailing duties on Indian solar imports will not impact its operations.

• Manufacturing largely aligned with domestic demand.
  
  

• Focus remains on India’s renewable energy growth and scaling high-efficiency capacity.
  
  

This reassures investors amid global trade tensions.

💉 Shaily Engineering Plastics

Shaily Engineering Plastics Ltd

Shaily secured a ₹423-crore manufacturing and supply agreement for pen injectors from a large domestic pharmaceutical company.

• Four-year contract
  
  

• Customer name withheld due to confidentiality
  
  

The order strengthens its position in high-value medical device manufacturing.

💊 Sanofi India Ltd

Sanofi India Ltd

Sanofi recommended a final dividend of ₹48 per share for FY2025, taking the total payout to ₹123 per share (including ₹75 interim dividend).

Q4 Highlights:

• Revenue up 47% YoY to ₹251 crore
  
  

• Domestic sales growth of 23%
  
  

• Profit after tax up 50% to ₹66.5 crore
  
  

Strong earnings and dividend payout make it a stock to watch.

📌 Market Outlook

With corporate actions including OFS updates, rights issues, dividend declarations, regulatory inspections, leadership changes, and major contract wins, February 26 is set to see active stock-specific movements.

Investors should monitor:

• Government stake sales (IRFC)
  
  

• Capital infusion plans (Tata Capital)
  
  

• Regulatory developments (Lupin)
  
  

• Dividend plays (SBI Life, Sanofi India)
  
  

• Growth contracts (Shaily Engineering Plastics)
  
  

• Renewable energy resilience (Emmvee)
  
  

Careful tracking of these updates could present short-term trading opportunities and long-term investment insights.